On 2026-10-06, Scotiabank raised its PFE price target to $33 from $30 (+10.0%).
Scotiabank 于 2026-10-06 将 PFE 目标价上调至 $33，此前为 $30，变动幅度 +10.0%。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
Cantor Fitzgerald raises PFE target to $28Cantor Fitzgerald 上调目标价 辉瑞 (PFE) 至 $28
Rating Change · October 8, 2026评级变动 · 2026/10/8
PFE receives FDA approval for as Front-Line Maintenance TreatmentPfizer Inc.（PFE）的 as Front-Line Maintenance Treatment 获美国 FDA 批准
Material Company Event · October 7, 2026公司公告 · 2026/10/7
HSBC raises PFE target to $30 from $28HSBC 上调目标价 辉瑞 (PFE)：$28 → $30
Rating Change · September 10, 2026评级变动 · 2026/9/10
